New patent for Ibsa Inst drug LICART
Annual Drug Patent Expirations for LICART Licart is a drug marketed by Ibsa Inst Bio and is included in one NDA. The generic ingredient in LICART is diclofenac epolamine. Additional…
The post New patent for Ibsa Inst drug LICART appeared first on DrugP…